Rhapsogen
1 known investors
Rhapsogen is developing a precision biologic therapy aimed at treating autoimmune diseases, focused on efficacy, safety, and durability.
Investors · 1
Frequently asked questions
- What does Rhapsogen do?
- Rhapsogen is developing a precision biologic therapy aimed at treating autoimmune diseases, focused on efficacy, safety, and durability.
- Who are Rhapsogen's investors?
- Rhapsogen's investors include Catalio Capital Management, LP.